Thursday, March 12, 2015 12:55:38 PM
This is a startup life science technology firm... with no real product on the market and thus no revenues... AXDX would like to be added back to the Russell 2000 index a mid 2015... the market cap needs to retreat well back from the $1B range... would be target around $500M-600M range... that would allow these SHORTs to make a very nice profit... and get AXDX back on to the Russell 2000 Index... that creates demand to fill the index funds / portfolio holdings... and will drive PPS back up to over $30PPS...
These "hack" articles don't actually know any science... and investors have been treated more than fairly since the new management took over... and the science is real... with significant NIH grant funding... to prove its potential viability... AXDX is a fun roller coaster as it is a pre-revenue company... the volatility introduced by these SHORT hacks gives me the opportunity to BUY LOW and SELL HIGH multiple times...
I will say this... I will BUY LOW toward the end of 2015 (after another SHORT hack)... and become very LONG on AXDX at that time... I feel this stock will go to $45 to $70 PPS in mid to late 2016 once the product is introduced... Molecular biology laboratories of every hospital will be placing orders for this innovative life saving technology.... and each hospital's Chief Legal Officer will require the device as well...
Let the SHORT hacks get us a very nice buy in point... and we can say thanks by end of June!!!
GO AXDX!!!
Recent AXDX News
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 05/10/2024 09:24:31 PM
- Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results • PR Newswire (US) • 05/08/2024 08:42:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:31:25 PM
- Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results. • PR Newswire (US) • 05/02/2024 01:30:00 PM
- Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results • PR Newswire (US) • 03/28/2024 08:05:00 PM
- Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results. • PR Newswire (US) • 03/07/2024 02:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 12:32:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 12:31:36 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 12:30:20 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:45:17 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 03/05/2024 08:59:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 11:59:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:48:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 09:12:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 09:11:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 09:11:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 09:11:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 09:10:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 09:10:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 09:10:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 02:20:45 AM
- Form 424B1 - Prospectus [Rule 424(b)(1)] • Edgar (US Regulatory) • 01/23/2024 02:59:53 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/22/2024 05:15:17 AM
- Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement • PR Newswire (US) • 01/19/2024 02:20:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/18/2024 12:19:47 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM